(Q43916589)

28 November 2017

title

Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine (English)

1 reference

Langerhans cell histiocytosis specific to childhood

28 November 2017

main subject

1 reference

3

1 reference

28 November 2017

author name string

Carlos Rodriguez-Galindo

1

1 reference

28 November 2017

Patrick Kelly

2

1 reference

28 November 2017

Gerald G Presbury

4

1 reference

28 November 2017

Martha Rieman

5

1 reference

28 November 2017

Winfred Wang

6

1 reference

28 November 2017

publication date

1 March 2002

1 reference

American Journal of Hematology

28 November 2017

published in

1 reference

28 November 2017

volume

69

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

179-184

1 reference

Clinical aspects of Langerhans cell histiocytosis

28 November 2017

cites work

1 reference

Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

21 January 2018

1 reference

Spontaneous remission of multi-system histiocytosis X

21 January 2018

1 reference

Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

21 January 2018

1 reference

Current therapy for Langerhans cell histiocytosis

21 January 2018

1 reference

Oral methotrexate and alternate‐day prednisone for low‐risk langerhans cell histiocytosis

21 January 2018

1 reference

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

21 January 2018

1 reference

Cyclosporine therapy for refractory Langerhans cell histiocytosis.

21 January 2018

1 reference

2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis.

21 January 2018

1 reference

2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients

21 January 2018

1 reference

Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature

21 January 2018

1 reference

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

21 January 2018

1 reference

Clinical and toxicological aspects of the antineoplastic drug cladribine: a review

21 January 2018

1 reference

2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia

21 January 2018

1 reference

Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies

21 January 2018

1 reference

Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues

21 January 2018

1 reference

Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy

21 January 2018

1 reference

Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin

21 January 2018

1 reference

Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'

21 January 2018

1 reference

Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity?

21 January 2018

1 reference

Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.10053

1 reference

28 November 2017

1 reference